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A complete evaluation of 
finement on man  a s  experienced 
e- 
the effects of long- te rm weightlessness and con- 
during an  extended space miss ion  rcqui rcs  a 
number of biochemical tes t s  s imi la r  to those per iormed fo r  the physician by a 
clinical  laboratory,  
part of the mission,  o r  post-flight, on specimens obtained during the flight and 
s tored,  
90 days) and because of the l imitations imposed by flight conditions. 
These t e s t s  may  be accomplished in  two ways: in-flight as 
The s torage problem is unique because of the duration anticipated (up to 
The preserva t ion  of biological samples  presents  a minor  problem in most  
clinical  l abora tor ies  clue to the shor t  t ime interval  between sample collection and 
actual  analysis.  
samples .  
lems, not normally encountered in the laboratory environment. 
When delays a re  anticipated, it is  customary to r e f r ige ra t e  the 
Longer s torage t imes ,  however, introduce unique preserva t ion  prob-  
The purpose of this study is t o  c r i t i ca l ly  evaluate a number of methods 
fo r  preserv ing  biological specimens,  to determine the feasibility of using the 
methods in flight, and to r e c o m a e n d  a method o r  combination of methods for  
preserv ing  and storing specimens collected during space flight for  post-flight 
analysis .  
consideration for  the Apollo Applications P rogram.  
ones considered for  preservat ion and s torage in  this study. 
Table 1 presents  a list of the clinical  laboratory evaluations under 
These p a r a m e t e r s  a r e  the 
P rese rva t ion  methods considered include : 
C h em i c a1 
Refrigeration 
. Freezing 



















TABLE 1 .  - LIsr  OF PARAMETERS AND SPECIMENS TO n E  CONSIDERED 
Feces  
Whole 
blood P a r a m e t e r  -- I-.IU-.r--Y--..- ----- --- 





Antidiuretic hormone (ADH) X I x  
X I Antihemophylic gloLulin (AHG) 
Bicarbonate 
~ . _ _ _ _ _ _  
X 
X 
BUN X I 
Calcium X I x  
Caryotyping X I  




Clot re t rac t ion  
________I_ _______ 
X --I.- X 
X I  
Clotting t ime X I  
Creat ine  X I x  
Creatinine X I x  







He ina toc r i t X I  
Hemoglobiri X I  
17 -Hydr'oxycorticosteroids 
Inlmune bodies X I 
Lact ic  ac id  -/- LDH isozymes  Magnesium 
Manganese X I x  
bIethc.moglobin X I  
hlucoprotein:; k related biocolloids 
N P N  
P B I  (protein bound iodine) 
Phosphates t X X ________ P l a s m a  throniboplxstic component (PTC)  




















TACLI? 1. - LIST OF PARAXIETERS AND SI’ECIX‘:II.;S TO BE COiiSIDERED - Concluded 
1 2 5  P1asr:ia volume ( R E A  ) 
Platelet  adlirsivcness 
P la te le t  count 
Potass ium 
Prote ins  ( el e c t r o p!io r e s i P ) 
Prothrombin  activity 
RAC ce l l  m a s s  ( isotopes)  
RRC survival  




Standard clinical analysis  
Sulfates 
Thyroxine 
Thyroxine binding prcalbuxnin (TBPA) 
Total  ni t rogen 
T r a n s f e r r i n s  
Ur ic  acid 
WHC differential 
WRC motility and phagocytic activity 
WBC (total)  , 
Zinc 
Microbiological parameters  
. _ _ _ _ ~ _ _ _ .  
________.___ 
__ __ 
_ _ _ _ ~ _ _ ~ _ _ _  
--___ 
_ _ _ _ _ _ _ _ _ . ~  
I-_-- 
__ 


















X I x  
X 
X 
X I  
X I  I 
Standard clinical analysis  inclildes: volume, color, turbidity. specific gravi ty ,  pI1, albumin, sugar ,  
ketone bodies, microscopy. 
hiicrobiological paranic tc rs  include: 
Sampling and Culturing of F lora  Eody 
Colony Counts 
Microbiological Idcrltificatiolis 





















Absorption and ion exchange 
Lyophilization 
Special biological problcms such a s  hemolysis , protein precipitation , con- 
taminant mjcrobial  growths , and the u s c  o i  anticoagulants , a r e  considered and 
evaluated. 
a r e  included. 
Recommendations and  rationale f o r  specimen prcserva t ion  and s torage 
SPECIMEN PRESERVATIOI\T TECIlNIQUES 
General 
A major  considerati.on in  tlie storage of biological samples  is the mainte- 
n.ance of the stabil i ty of the specimen during the interval  between the t ime of col-  
lection and tlie t ime analysis  is begun. Many organic substances a r e  subject to  
deter iorat ion due to bac ter ia l  contamination o r  to tht action of enzymes present  
-- in  situ. 
problem when the sample  i s  to be  stored fo r  longer than one clay e i thcr  at room 
The effects of microbial  growth a r e  la rge ly  unpredictable and become a 
o r  re f r igera tor  tempera ture .  
vironment fo r  the collection and storage of all biological mater ia l .  
This problem can  be solved through a s t e r i l e  en- 
However , it 
is usually mo're prac t ica l  to f r eeze  the sample o r  to employ an  ant ibacter ia l  
agent. 
growth. 
be  blocked by addition of a specific enzyme inhibitor. 
may bc adjusted to a pH value a t  which the enzyme i s  no longer active.  
Acidification of the sample may a l so  be  employed to r e t a rd  microbial  
The degradation of organic mater ia l  result ing f r o m  enzyme action m a y  
Alternatively,  the sample 
Table 1 lists a number of elcinents and electrolytes  which have high in-  
herent  stability. 
chloride , magnesium, manganese , potassium, sodium, and zinc. 
These inorganic substances include bicarbonate , calcium, 
In pract icc  , 
4 
I -  
storage of biological sai-riples containing ii7orgnnic substances at 1-ooim tcmpcra-  
t u r e  o r  even under re f r jgcra t ion  f o r  sevcral  days leads  to c?. precipitation of pi*o- 
te in  o r  inorganic niater ja l ,  o r  t o  a growth of microbial  contaiiiiiiants. 
supernatant is l a t e r  sarnpled without regard to tlic debr i s  present  in these Iieicr- 
ogcneous spccimens,  se r ious  e r r o r s  may resu l t  in  the analysis.  





Urine collections m a y  b e  made by methods discussed in Lockheed Report  
I M-61-61-1-1. 
s tored  in plastic containers.  
sample m a y  be  obtained by fingertip puncture and drawn 5nto capillary tubes for  
subsequent analysis.  Where l a r g e r  amounts of blood o r  p lasma a r e  required,  
the specimen normally is obtained by venipuncture and thc blood is discharged 
iiito tulles containing a n  anticoagulant. 
omitted f r o m  the collection bottlc. 
dcveloped fo r  NASA. 
Sweat is absorbed in  gauze as  dcscrjbecl by I3enry and may  bc  







I F o r  s c r u m  specimens the anticoagulant is 
Feces m a y  be collected by methods previously 
Many of the p a r a m e t e r s  norinally found in whole blood a re  p rcsen t  in  un- 
equal concentrations in t h e  erythrocytes and in  tlic extracel lular  p lasma phase.  
In those instances when the parameter  is  present  p r imar i ly  in the erythrocytes ,  
it is necessa ry  that  the analysis be perfoymed on whole blood. 
quired f o r  analysis  of hcmoglobin and methemoglobin, and for many of the hema-  
tological studies. P l a s m a  is specified f o r  blood voluinc cletcrmination, amino 
nitrogen, and fibrinogen, as well as  fo r  studics in  clotting dynamics. F o r  m o s t  
biochemical tcsts, tlic specjinen of choice is  sc rum,  whose preparat ion does not 
requi re  tlie use  of an anticoagulant. 
1 Whole blood is r c -  
. 
I 
It m a y  be noted t h a t  the prcparation of scrurn and p lasma rcqui res  thc i r  























the blood is obtained to prevent secondary cliaiigcs i n  the specimen. 
purposc, a spaceborne laboratory centriiuge o r  its cquivalent rnusi be considered. 
F o r  this  
The relative m e r i t s  of var ious methods of sample preservat ion are evaluated 
Each topical heading is supported below f o r  each  type o€ spccimen l is ted in  Tablc 1. 
by data i n  the related table. 
correspond to  a l o s s  of l e s s  than 3% i n  each  pa rame te r .  
required for  each  analysis  a r e  l is ted in  Table 2.  
basis for  determining minimum sample qi.antities when a l l  pa rame te r s  a r e  to be 
analyzed in  a given specimcn. 
The periods o i  stability given i n  these tables generally 
The sample quantitics 
This table m a y  be einploycd as  a 
N o t e s  and abbreviatione applicable to Tables  3 through 7 a r e  contained in 
Appendix A. 
Urine 
Untreated ur ine s tored  at: room tempera ture  is unstable for  a significant 
number of the 18 designated parameters. A s  indicated in Table 3 ,  changes occur  
in  creat inc,  sugar ,  ketone bodies and p H  wjthin seve ra l  hours  after the urine 
collection is macle. 
a t  room tempera ture  in the absence of prcscrva t ives .  
p a r a m e t e r s  tend to be more  stable. 
chlor idcs ,  magnesium, manganese,  potassium, sodium, and zjnc a r e  stable for  
long per iods of t ime,  but a s  noted previoxsly, there  is  a tendency fo r  these 
substances to  precipitate or co-precipitate during standing. 
that  the ur ine  specimens be acidiiicd to  dissolve thcse deposits pr ior  to  analysis .  
Catecholamincs and aldosterone a r e  stable fo r  onc to two days 
Most of the relnaining 
Inorganic constituents, such as calcium, 
It is therefore  necessa ry  
A number of chemical agents have been used to preserve  ur ine specirncns 
at room tcmpc1:ature. Among the sc agents a r e  forrnaldehydc, toluene, chlorolorni,  
6 
TABLE 2. - APPROXIMATE MINIh4UM SA>,IPLZS REQUIRED FOR ANALYSIS I N  SINCLIC.4TE 
P a r a m e t e r  
Adrenocorticotrophic horinonc (ACTH) 
Aldo E, te r one 
Alkalinc phosphatase 
Amino nitrogcn 
Antidiuretic hormone (ADIT) 








Clot r e t r ac t ion  
Clotting t ime  
Creat ine 
Creat inine 













Mucoproteins & related biocolloid8 
NPN 
P U I  (prote,in bound iodine) 




4 .0  









- - -  
2.0 
0.05 
_ - -  






- - -  
..- 
- _ -  
--- 
0. IO 









NOTE: Values a r e  e s t i n ~ a t r s  based on cu r ren t  uqage. 
employing ul t ramicro analysis  techniques,  or by pcrfur,ning two o r  more anzlyses  on tlic samc spccinicn 
Sornc sl lnplc  rcquirzmcntu m a y  bc r,educt.d u p  tu 5070 by 
TADLE 2. - APPROXIhlATE MINIhlUhl  SAMPLES REpUIRED FOR ANALYSJS IN SINGLIC.k’A’E - Concludcd 
Pa ra inc tc r  
P l a s m a  th romtcp l s s l i c  conlponent (PI‘C) 
P l a s ~ n a  volume (RISA ) 
Platclet  adhcsiveness 
Platelet  count 
Po ta s s ium 
Pro te ins  (e lectrophoresis)  
P ro th rombin  activity 
.RDC ce l l  ma88 (isotopes) 
RBC survival  
RBC (total)  
Reticulocyte count 
Serotonin ( 5  -IIIAh) 
Sodium 
Standard clinical  analysis 
Sulfates 
Thyroxine , 
Thyroxine binding prealhumin (TDPA) 
Total  nitrogen 
T r a n s  ft.r r ins 
Uric  acid 
W BC diffe rcn t ial  
WBC motili ty and phagocytic activity 
WBC (total)  
Zinc 
125 
























- - -  




- - -  
_ - _  
--- 
- - -  
- - -  
0.05 
- - -  
1.0  
1.0 
1 .0  
--- 
0 .  l o  
0.10 
_- -  
- - _  
--- 
2.00 
Feces  Sweat 
g. ml. 
NOTE: Valucs a r c  cs t i rnates  based on  cu r ren t  usage.  
employing u l t r amic ro  analysis  techniques,  o r  by pcrforming two o r  more  analyoes on the sarnc spccrmen. 






















































TABLE 3 .  - DURATION O F  STABILITY 01;' 
URlNARY CONSTITUENTS - C011~1uded 
Calcium tcuds to precipitate in  the absence of acid. 
analysis  by  addition of acid. 
It i s  redissolved pr ior  to 1 
'Samples a r e  bes t  analyzed soon after collection to avoid precipitation of var ious 
constituents. 
adding a s m a l l  amount of acid. 
If  a precipitate is present i t  i s  redissolved pr ior  to analysjs  by 
3r rhe  sample  i s  s table  for  severa l  weeks provided there  a r e  no r ed  ce1l.s present.  
4Standard Clinical Analysis a lso includes: volume, color,  mic ros  copy, spzcific 
gravity, and turbidity. 
Acetoacetic acid is quite s table  in s o m e  urines at room tempc>rature but clis- 
appears  rapidly in others ,  the disappcarance appearing to be related to mic ro -  
bial  action. 
i n  less  than 24 hours ,  whereas  j i  the solution i s  s t e r i l e ,  i t  is stable for  8- 10 
days. About 2 0 %  of the acetone present  disappears  in 24 hours  a t  room tem- 
pera ture ,  but none is lo s t  in  the sarnc period ii the urine is kept in a closed 
container in  the re f r igera tor .  Ketone bodies m a y  also disappear i ro in  urine 
in vivo in the presence of a ur inary  t rac t  infection. 
5 
In the presence of bacteria o r  yeast  i t  mc2by disappear completely 
-I I__ 
The spec imen is s table  for  4 hours  provjdcd i t  i s  not heavily contaminated with 
bacter ia .  
6 
Cargi l le  ur inary  preservat ive tablets buffer the urine to a pII of about 6 .  
a r e  a mixture  of benzoic acid, fornialdehyde (produced f r o m  urotropin),  and 






















and C ~ d O l ’ O f O l J l ~  a r c  objectionahlc f o r  jn-flight use  due t o  the i r  volatiljty 
ious chai-acier. Thcrc  a r e  indications that iormaldeliyde m a y  i n i e r i c re  
These subsIances a c t  p r imar j ly  as antimicrobial agel,ts. Tol.uci~e 
and llOX--  
with thc 
d e t c i  n i i v t i o n  of glucose jn ur inc  when ernp!oyccl in  excessive c1uai7tiiiese 
r ide  i s  a toxic age;)’:, and is a l so  objectionable becausc: it teiids to precipitate 
calcium irom urjnc0 
achieved thc widest acceptance in practice.  
Cargi l le  and Urokeep a re wjdcly used cliiiically fo r  preservat ion of ur ine  speci-  
mens.  
Fluo- 
Thymol, benzoic acid,  boric  acid,  and mine ra l  acids  have 
Coinmercial  u r inary  tablets  such as  
Cargi l le  tablets buffer the urine to  a pJI of about six and contain a. mixture  
of benzoic acid,  urotropili,  and mercur ic  oxide. 
tablets has  no t  been specified. 
The composition of Urokeep 
Boric  acid is  effective in  maintaining the stability of aldostcroiie, 17- 
hydroxycorticosteroids,  and 5-hyd1-oxyindoleacetic acid fo r  periods of approxi- 
mately one weck. However, boric acid is  ineffective i n  thc prescrva t jon  of 
catecholamines,  for  which s t ronger  acid is required.  
agent is potassium bisulfate, used in amounts of 200 m g  per  ounce of u.sine (pH 3 ) .  
This substance mill p r e s e r v e  the ur icary  catecholamines for  one to two wecks at 
An efiective stabilizing 
30°C. Urine acidified to pH 3 a lso  p rc sc rves  the activity of antidiuretic hormone 
f o r  onc week: To maintain the inorganic p a r a m e t e r s  in solution, m i n e r a l  ac ids  
are cus tomar i ly  used. These acids  p re se rve  calcium, chlorides,  potassium, 
sodium, zinc, and other  inorganics € o r  per iods exceeding six months. 
As indicated in i-he l a s t  th ree  columns of Table 3 ,  urinc may  be stabil ized 
s imply and efiectively through rcduccd s torage  temperatures .  Freczjng will 
maintain the stabil i ty o i  virtually a,ll para ine tc rs  for  per iods of 90  days o r  more .  
Lyophilization appears  to bc eiicctivc for  m o s t  p a ~ a m c t e r s ,  with the iiota1~l.c cx- 
ception of kctone bodies, which m a y  unclcrgo loss due i o  volstilixation of acetonc. 




















Seruiii and Plasma 
Table 4 l i s t s  35 pai-aineters wliosc a,nal.ysis js required f r o m  scru-m. o r  
plasma, 
men ,  but plasma i s  required f o r  the fol.lotving parsrnetci-s:  
hemophylic globulin, fibrinogen > fibrino1ytj.c activity,  p lasma tlir onlbopla s t ic 
component, plasma volunic (RISA 125), and pr.othrombin activity. An important  
consideration in handling se run i  and plasma is the avoidancc of unnecessary ex- 
posure  t o  sunliglit, ultraviolct  o r  cven thc u.sual lighting i.n a laboratory,  s ince a 
50% 10s s .in uiicoiiju.gatcd bilii-ubiji iiiay result wi'ihiii two ~ U U T S .  
In most j.nstances the analyst has the optioa of selecting ei thcr  speci- 
amino nitrogen, anti-  
In the absence of preserva t ives ,  a number of p a r a m e t e r s  deter iorate  at 
room tempera tu re  within hours  a f te r  the blood coll.ection is  made. 
s tances  falling in  this group a r e  ACTH, amino nitrogen, antidiuretic hor-mone, 
antihemophylic globulin., crea,tine, fibrinolytic activity, and plas-ma thrombo- 
plast ic  component. 
sha rp  con t r a s t  to ur inc,  where the hormone has great ly  eiihaiiced stability. 
Table 4 presents  specific data on the remaining 28 p a r a m e t e r s  i n  uiiprocesscd 
serum and plasma.. In general ,  it may be  noted that untreated spccirnens a r e  not 
acceptable fo r  analysis  beyond brief periods of s torage,  with the exception of the 
ino rganic constituents 
The sub- 
The noted instability of antidiuretic hormone in plasiiia is in 
As with other  biological mater ia l s ,  s e r u m  and p lasma teiid to  putreiy 
a f te r  collectjon wiIh accompanying degradation of organic constituents. 
and thymol aye most commonly used a s  blood prcserva t ivcs .  
ant ibacter ia l  agent, while fluoride has  inhibitory action on cnzyincs involved in 
glycolysis. 
anticoagulant. 
l i ty  of BUN is incrcascd f r o m  onc to five days,  amino nili-ogcn f r o m  eight hours  
Fluoride 
Thymol ac t s  as an 
Fluorjdc a c t s  concoinitantly a s  a weak antiriijcrobial agent and as an 



















































































































































































































































































Lyophilimtioii has  provcx  cflCcctivc f o r  prcscrvat ioi i  of many of the pa , r s -  
Exceptions a rc  plasma proi-h.rom1)j.s activity and aiitj - 
In a s!'gn.ifica,nt numbcr 
m e t e r s  l j s ted  in Table 4,. 
heinophylic globulin, both oi w1iic.h a r c  highly unsta.l~le 
of instanccs  there  i s  a dearth of iniorma,tioii on the stability of the pa ra inc t e r s  in 
the lyophilized state. 
dctcrniine the usefulness of lyophjlization as a preselvc?..tion tech!'.quc. 
147urtiicr laboratory studies would appcar warran ted  to iully 
Reirj.gera.tj.on o i  specinieiis at 5 O C d o e s  not appear to bc an acc:cptal>lc, 
method of lon.g- terrn preservat ion for either Sel'UiJ1 o r  plzisma. 
ditions, pa rame te r s  such as amino nitTogcn, antidiu.1:etic hormone., LDT-? isoz..yiries, 
c rea t ine ,  crea,tinjiie, pla,snza thromboplastic C 0 1 1 1 ~ 0 1 ~ C i l t ,  and p:r .otl~om.bin activity 
a r e  s table  fo r  l e s s  than 2 4  hours .  
per iods of t ime,  but there  is  no  n-ia:rlied impi*ovci-ent over st.orage at room t e m -  
perature. 
seru- rn  specinieii m a y  b e  s tored  f o r  a month under rcfri.geration. 
noted that so:ne invest-igators claim alteration's occur in  the 01 - and /3 -giohul.ins 
despite refr igerat joa.  
Under thesc coli- 
The other substances a r e  stzlde fo r  longer  
W i t h  regard to proteijis by clectrophoi-csis, the table indicates that  thc 
It should be  
16 




















Of the 17 t c s t s  dcsignalcd f o r  whole blood a s  shown  in  Table 5, 1 3  arc  
heimatol ogic whlle the reinaindcr  a r c  biochci-nical. It is  the hematologic tcsts 
w1iiclJ posc tlic greatest difficulty i n  stored blood spcciinc-11s. 
The biocheinjca-1 garamctc3’s required in whole blood a r c  hemogl.obin, 
terim storage.  
na..t.ively, blood i s  t r ans fe r r ed  to pap“” a s  a dry f i lmo 
gl.i~cosc and hernoglobin contents a r e  s table  f o r  c.xl:e!:dcd periods of tin-je. 
F o r  long- te rm storage the blood may bc i rozen  t o  - 7 9  “C. Altcr-. 
In this form both the 
Both 
lac t ic  ac id  and mcthenioglobin 2 re uns’lable in unI reatcd blood s p c c i ~ ~ i c s i s ,  hut 
rnethei-rioglobii; niay be mxjntainccl fo r  thi c c  months o r  m o r e  i n  i rozen blood. 
There i s  a lacl-. of data  oii l ac t jc  c?.cicl slahility in  f r o z c n  bloocl, although l sc t ic  
acid m;ty bc preserved as a11 ext rac t  by dcproteinizing the blood saxip le  with 
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tcndcd per iods  of t ime. 
param-tcters j.11 an unchanged f o r m ,  
dur ing  the frcexc-thaw cycl.~:, chemical. addi.t:ivcs a r e  n.nccssay-y. 
(1 949) discovcred the protective action of glycerol in the freezing of spcrmatozoa 
Iii 1950 Smith reported tlic: protection o f  n l i ~ , ~ ~ ~ m ; l . l i ~ ~ ~  rcd cel1.s by glyce~:ol. nsin.;]; a 
s low freezc-thaw t.echnj.qne. 
tivc a g a i n s t  i r e c z i n g  i n j u r y  (1,ovelocl; and  Bishop, 1959). Rapid-freeze tec1inicluc.s 
havc also bccn investigated. using inaci:oiilol.ecul.ar additives, such  as  P V P  a,?id 
clclitr1.aii (Ericka and Be s sis, 19 5 5; Rinlret) 
Blood s to red  j .n  this niannei- conia.ins ivos t  b.i.c)c.lieIdca.l 
To  rnaS.iitain t:bc jiitegj:it.y c d  the blood cells 
l?ol.ge -- e t  -. a.1.. 





















The lability of the ’blood ce1.l.s du r ing  thc ~ I - O C C S S  of cool ing  t o  s torage 
tempcyatu-re i s  a. nistkr of ccniccyn t o  spccia?ists in th.e ficld. 
h a s  inade the €01.1 owiirg coiriinents on t1ii.a mat ter :  
1itcratu:i.c that t.71~ lower  t h . ~  s torage tCj-rjpc>:attlre the bettcr the chance i s  f o r  
l o  11 E - t e r i n  p r e s c I v a t i  o !i c oriv c 11;. e nt s to  r n g c t einp c atu e i s 1 i qui cl 
nitrogeli a,t -196 “ C ,  where 13.0 biological cl!:Lij.gc:s havc  becn ObSej:vCd, a s  opposcci 
t o  ohscsva.ble c h . a i l g ~ : ~  noted at h i g h e r  cieg~:cc..; such as  - 8 0  “ C ,  o s  t1J.c tcx-nperaturc 
oi d r y  i ce ,  solid COz0 Storage,  theil, does  not Seej.r? to  pi-ese1l.t any prob~.eJ23., but  
rather tlic problem l i e s  in  the inethod of getting Clo~ii.~ to  the stori.age tci-npci:a,!i:urc 
and. tllcji getl . i~.~g back u p  f r o m  the lower stora.ge temperatu.re to  ambient  tcmpera- 
turc. 
Dr.  Rov~e (1.967) 
“It is  well cloc~~-r~ccnted j n  the 
The mo s 
21 
( 3 )  There is a paucity of data. in tlie 1i.tcra’Lu:t.c yerta:i.njng to thc stabilit): 
of the I.~cmatologic paj:S-il?etc:cs i n  whole blood I.istcd in Table 1; most stability 
si-udies a r e  coiicerned with t11.c recovery of ce1.l.s f o r  tramsfusion gurposes. 
I 
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f o r  dcterinjnation of scrurn hili 1 ubiii, thcil any degj*ec 01 hcinolysis i n t c r i c rc s  in 
the azo-coti-pling reaction and results ia clccreasccl levels ,  li may a lso  be notcd 
that hemolysis affects the analysis  of total protejn by the biuret  reaction. How- 
eve r ,  this  jntcr ierence may be O V C r C C i l 2 e  by process ing  a scru in  blan!:. Other 
aiialyscs that are influenced (elevated) by hemolysis  a r e  N P N ,  lact ic  acid and 
pyruvic acid,  
Most  chemical  analyses  are ca r r i ed  out on s e r u m  ra thc r  than p lasma,  but 
plasma i s  requi re6  f o r  a substantial  number of tes ts .  In preparing plasma it i s  
necessa ry  to  avoid hemolysis  by u s e  of the proper  anticoagulant. Sodium fluoride 
is an  effective anticongt~l.ant but i s  employed in relatively high coilccntration. 
Undcr thcsc  condjtions it is  likely to  yrocluce hemolysis a s  tvcll a s  sigiijficant 
shii ts  in  tvatcr f rora  the blood ce1l.s t o  plasma. H e i ~ ~ o l y s i s  m a y  a l so  0ccu.r <he  to 
improper  u s c  of oxczlste a s  an anticoagulant. 
Antjcoagulauts --- - Chemical reagents that prcvci-it coagcllntioi-i arc rout i l idy 
used  when whole blood o r  p lasma i s  required fo r  analysis.  
the i r  action to inhibition of conversion of prothrombin to thrombin by thc removal  
Antjcoagulants owe 
of calcium ions (fluoride, oxalate, c i t ra te ,  EDTA) o r  by other mechanisms 
(heparin). 
in te r fe re  with the analyscs  which a r e  to be conducted, 
causes hcniolysis when employed in  high concentrations which m a y  contraindicate 
i t s  use,  although it may bc acceptablc in lower concentrations ( John ,  1926) .  Thc 
use  of fluoricle is  contraindicated when p lasma enzyincs whose activity is  inJiibited 
A p r i m c  considcration in  t l ~ c  lmicc of an anticoagulant i s  that it not 
As notcd abovc, fluoride 



















; I  
P I  a snia c ont  ai nj rlg c 2.1 c j v  1-1 1 -. r CI nov j 11 g a3 i t  IC oagula ilt s ( oxaiatc , c i t  r at c , 
EDTA) cannot be used f o r  ca1ciu.m deterniiaatioiis 
o r  potas sjum salts of ailtic:oag~~lants i uusujtcd €or  sodium o r  potassium d e t e r -  
aiid p l a s ~ n n  containing sodium 
niinatjoiis. 
of S ~ ~ ~ L I I I I  03' cslcjiim a s  thc sa l t ,  a n d  t h i s  m a y  d t e r  resu l t s ,  
nique is uscd  f o r  detcriiiining u ~ e a  nitrogcn, the sample m u s t  not be collected in 
a tube containjng an enzymc inhibitor o r  ail i jcoagulants containing ammonium 
sal ts .  
be assayed for  urea nitrogen b y  direct  C I L C M ~ L  
m o i ~ o ~ j ~ n e  procedure.  
IIcparin a t  a coiicentration o€ 0. 5 mg/ lO  nil contains a sinall  amount 
I€ a urease tech- 
However, p lasma o r  whole blooc! collected with these enticoagulaiits m a y  
1 methods,  such a s  the diacetyi 
A ser ious  objection t o  I h e  use of oxalates as ariticoagulants l i e s  in the 
al terat ion of concentrations of plasma. ~ o i n p o l l c ~ ~ t s .  
siurn oxalatc m a y  be 10% l ess  than that obtained with heparin.  
erytl i iocytc volume rcsu l t s  f r o m  a waster shift from the erythrocytcs  t u  the 
plasiria caused by the addition of thc salt to tlic p lasma phase.  
The h e i ~ i a t o c ~ * i t  using. potas  - 
This reduced 
A 10% clcci-ease in 
heinatocr j t  results jn a dilution e r r o r  of p lasma constituents of 5%. 
watcr  shifts a re  a l so  caused by sodium c i t ra te  as well as by sodium fluoride 
vi~licn cniployccl i n  r e h t i v e l y  high concent rations. 




I Iowcver ,  it has  been reported t o  int e r i e r e  with the dcterniination 
of protein.  
3 -4 



















hiaclcquate iiiioJ.imafion cxis ls  a t  this  t ime t o  prnpe?.ly deiiiic tlic quantity 
o i  specinTci-is which i i iay  have i o  hc storccl for  a given mjssion. 
that  in  orcles- to  per for in  a11 Ilie tests spcciijed in Table 1 , inorc' t han  20 ml  of 
s e r u m  i s  requjrcd. This ,  i n  turn,  requires 50 ml of whole blood - a quantity 
which must be obtained b ~ -  v m o u s  pnncturc.  
logically usia~ccpta.ble i f  ObiiLiiied on a clc~.;ly bas i s  , so,  fo r  purposes  of thjs analy- 
sis ,  a weekly interval was selected.  A l s o ,  swcat a n d  feces  Xvere included in thc 
f r e c y e r  although freezing i s  no t  str ictly necessa ry  for  constituent stability-. 
Table 2 indicates 
Thj s would undoubtedly be psycho- 
It was as sumed  t h a t  20 nil of se rum;  36 ml o i  urjnc; 7 in! of blood; 4 g1.1- C i n s  
of feces;  and 4 in1 of sweat constituted a sainple set .  
ical  l abora tory  prac t ice  t o  pe r fo rm the tcsts in clvplicatr, tbc specimen s i zcs  
were  doublcd €01- a sccoiicl evaluation, 
Bcca,use i f  is  common c l i n -  
Twelve hours  are anticipated for lowering the teinperatu-re of tlic specimens 
f r o m  37°C to -80°C. 
wjthin two hours  , which insures  aclcquatc stabiljly o i  the pauai-ncters fo r  the r e -  
.paining ten hour s o 
Thc specimens would be at refr jgcrat ion te inpcra tures  
A systein ulilixing l iqu id  oxygen a s  the refrigeramt is envi sionecl. 
oxyzen woulcl bc boiled of1 with the heat of vaporizaticn providing the necessa ry  
cooling. 
The 





















Becav s e  of the wcjghtles s ei1vii*onlneni, convection current  s will not be 
esta1,li s h e d  witEjn tlic f,.eczei-. 
s torage of each spcciimcii adjacent to a re f r igcra ted  wall, 
Thercfore ,  the unit should be designed to  allow 
If a 90 day miss ion  is  a.ssumed and 12 sets 01 specimens a r e  obtainccl, the 
f r e e z e r  with its liquici oxygen supply would occupy 300 cubic inches,  weigh 15 
pounds and consume no power. 
sis ,  500 cubic inches and 22 pounds would bc  reyujred.  
If the specinicns are  obtained for  duplicate analy- 
The f r eeze r  box would occupy 65 cubic inches fo r  siiiglc samples  and 125 
cubic inches f o i  singles and duplicates. 
is discoiincctcd, The insulated box will re ta in  the spccjmeiis in a f rozen state fo.- 
m o r e  thaii eight hours.  This is sufficient time fo r  r e -en t ry  and recovery,  after 
which a cry0gcni.c supply could be attached a n d  the spcciniens t ranspor ted  to  the 
labo ra to  ry.  
Fo r  return to ear th ,  the cryogenic supply 
T RAD E 0 F F’ ANAL Y SIS AN D R E C 0 M M E N  1lR T IO N S 
In any. reconirnendatioii of nietliods for  preserva t ion  of biological speci-  
mens, the required s torage  t ime mus t  be specified. As these t imes  a r e  not coin- 
pletcly defined a t  p resent ,  a typical niission lirnc is a s sumed  f o r  purposes  of this  
d i scus  s i  on 
The s torage tiiiics presented in  the previous section have been quantized 
into typical rnissjon durations and a r e  prescntccl in F i g u r e s  1 through 5.  
pl-esuincd that experiments rcquirjng specimen storai4e will not be scheduled f o r  
miss ion  tirncs of l e s s  than 14 days,  
It is 





















grca ic r  t h a n  180 clays. V$herevcr inforjnziioii .is 1.1101i~n oii the stab?lity 
paranic te r  €or a given prcsc iva t ion  technique, an  enil-y has been ~ i - ~ a d e .  
whcre previously noted, no  tjmc s have  been extrapolated lxyoncl knoxvn 
p e r i o cl s . 
o€ a 
Excc p t  
stable 
It can be seen  f r o m  F'jgures 1 through 5 that the m o s t  c r i t i ca l  spec imens  
f r o m  the standpoint of stability a r e  w h o l e  blood, seruni and p lasma.  Very  few of 
the p a r a m e t e r s  specified f o r  thcsc specimens a r e  stable fo r  g r e a t e r  than 14 clays 
without f i eez jng .  
s torc  by Eny method. Even by using a combinaijon of free2,ing and dr ied  f j l m s ,  
only half of the p a r a m e t e r s  in whole blood can be errpcctcd to r ema in  stable €or 
typical i n i c  sj on d u r a t j  n:j s .  
In whole blood, the hernotologic p a r a m e t e r s  a re  cljffjcult to 
F igu re  6 p re sen t s  zn equipnient evaluation s n m i n a  r y  01 the vai-ious 
methods of preserva t ion .  
signifying equipment having minimum volume, weight a,nd power requi rements ,  
min imum complexjty , maxi niurn z e r o  gravity compatibjlity and maximum stability 
t ime .  On the othcr end of the sca l e ,  the rating of one signifies maximum volume, 
weight and powzt-, e tc .  
Thc rankings a r e  O i l  a one to four b a s j s  w j t h  four  
It can be s e e n  fro-m this tabulation that s torage without any 
prescrva t ion  is  the easiest t o  rrtcchanize but  results in  unacceptably sho r t  stability 
times for m o s t  pa rame te r s .  
al lows a longer storage period for some pa rame te r s .  
Cheiiiical p reserva t ion  is  slightly m3re complex but 
Refr igerat ion o f f e r s  l i t t le advantage over  f reezing,  par t icular ly  i f  





















Lyopllj.l.i;..atioii is the rnost c o i i ~ p ~ c x  of the iziethods and offers a n  advantagc 
over  fi:ec.ziiig in only alie irist.ance: 
rcquireinr.i:t f o r  this para..meter shoulcl bc carefully a s s e s s c c l  and al tcrnat ivc 
rnctt:hods of obtaining the ineasurei-nent investigated before estr~.blisl~iiig the requi re  - 
m e n t  f o r  a lyopl~i l izer .  
LDII i sozymes  in  serum o r  p lasma.  The 
It is  recoiiimencled, tliei- fore, that  development of a space --qualified 
specinicri f r e e z e r  a,i~cl s torage unit be t11jclert:ll:cri f o r  the preservat ion of whole 
blood, u r i n e ,  s e i  tin? ziid PI:) sinx. Additioii;~Ily, provisiou shou ld  be made for  
obtaining d r j e d  l~ lood  srnears on papcr  o r  g l a s s  €or  plaiclet  C O U L ~ ~ ,  rcticiilocyte 
count, amd WBC diiierential .  
feces  i s  re la t ively uniniyortant f o r  the paratiwters specified, th:: f r e e z e r  could be 
used f o r  these spec jmens  with little pciixlfy ir! s i ze ,  weiglit a n d  power Over a l i c r ln t e  
s torage  imethods.  
While the method of prcscrva t ion  f o r  sweat  ancl 
The vo The voluine, weight aiid po\w r requi rement  for  the s p c  cinien f r e e z e r  hzve 
been prcseiitcd i n  the previous section. 
e s t ima ted  and 15 to  22 p o u ~ d s  f o r  wejgllt.  
re  qui red  . 
F o r  V O ~ L L ~ C ,  300 to  500 cubic inches were 
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Notes and Relercnces Applicable to  Tables  3 Through 7 
Notes 
1. I1Stable" signifies stabiliiy €or an extendcd period of t ime,  exceeding 
two to three  months. 
2. Arabic numera ls  r ep resen t  footnotes 
3. Refrigeration signifies a tempera ture  of about 5 "C. 
4. Freez ing  indicates a temperature  lower than -10°C. 
5. The data in the "Without Preservat ive" and "Preserva,tive" columns r d c r s  














= Calcium oxalate 
= Citrate  buffer 
= One Cargi l le  tablet  p e r  ounce ur ine 
= Di sodium e thy1 enediamine t e t  raac e t at e 
= Fluoride 
= Boric acid 
= 'Sodium fluoride 
= Oxalate 
= Pet ro leum ether  





















PrA = Pc~~c l i lo i - i c  a id filtrate 
















= Verona1 bufier 
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